Lincolnshire, IL – April 2009 – Dr. Amy Forman Taub, board-certified dermatologist and Assistant Clinical Professor at Northwestern University Medical School, is featured in the April 2009 issue of North Shore Magazine. In an article focused on Dr. Taub’s education as an artist and dermatologist, author Eric Johnson speaks with Dr. Taub on using artistic techniques combined with medical technology to recreate the appearance of youthful skin. The procedure most talked about is the Matrix RF by Syneron, a device cleared by the FDA for the ablation of soft tissue and skin resurfacing. This represents the first ever radiofrequency device approved for skin ablation and resurfacing. Dr. Taub was one of four physicians to participate in the clinical trials for the Matrix RF. Dr. Taub stated, "In my trials, I have found that Matrix RF results in a unique combination of skin rejuvenation, wrinkle reduction, skin tightening and even lifting with less downtime than traditional skin rejuvenating treatments. My patients are pleased with the fast, visible results of smoother, brighter and tighter skin, without having to sacrifice time from their busy schedules." Dr Taub is the first physician in the Chicagoland area to introduce this new technology into her clinical practice.

The Matrix RF is the only RF device for skin resurfacing on the market. It treats minute skin areas, leaving the surrounding untreated skin areas intact to act as healing reservoirs for the thermally damaged tissue. The undamaged tissue promotes quicker healing and ensures limited patient downtime while speeding the appearance of desired results. The tunable Matrix RF applicator is equipped with the SelectPulse™ to enable customization of the depth of ablation and degree of skin resurfacing based on individual patient needs. Three different modalities can be emulated due to this software and technology: erbium glass fractional resurfacing, carbon dioxide fractional resurfacing and YSGG fractional resurfacing. An average of 3-5 treatments is recommended to achieve optimal results. Tissue tightening and smoothness may continue to develop for up to six months post treatment.

Dr. Amy Forman Taub founded Advanced Dermatology, Skinfo® Specialty Skincare Boutique and SKINQRI in Lincolnshire, Illinois. Advanced Dermatology is a state-of-the-art medical and cosmetic dermatology practice nationally recognized for excellence in dermatologic care. Skinfo and skinfo.com, a professional skincare website, offer physician-dispensed and cosmeceutical-grade skincare products and product information to the public. In 2006, Dr. Taub founded SKINQRI, Advanced Research in Dermatology. SKINQRI collaborates with pharmaceutical and laser companies to test the safety and efficacy of new treatments and evaluate new protocols for current treatments. Dr. Taub's practice philosophy is one of active collaboration with her patients. While she likes being on the cutting edge of technological and medical innovations, Dr. Taub carefully evaluates the scientific principles and safety of new treatments and procedures she makes available to her patients.

Born and raised in the Chicago area, Dr. Taub graduated from Northwestern University Medical School in 1985 and completed her internal medicine internship and dermatology residency at its affiliated hospital, Northwestern Memorial, in 1989. Prior to opening Advanced Dermatology, Dr. Taub was the Medical Director for the Division of Dermatology of Northwestern Memorial Physicians Group.

As a consultant to leading laser and drug companies, Dr. Taub also educates and trains physicians from all over the country to provide cosmetic and laser procedures. Dr. Taub is a member (Fellow) of the American Academy of Dermatology (AAD), the American Society for Dermatologic Surgery (ASDS), the American Society for Laser Surgery and Medicine (ASLMS), the Chicago Dermatologic Society, and the Illinois State Dermatologic Society. Dr. Taub is also a Charter Board of Director for the American Society of Photodynamic Therapy (ASPDT), a member of the Leaders Society to the Dermatology Foundation, on the Advisory Council of the Skin Cancer Foundation, and on the Research Committee for the ASDS.